152 related articles for article (PubMed ID: 21044641)
1. Huntington's disease is a disorder of the corpus striatum: focus on Rhes (Ras homologue enriched in the striatum).
Subramaniam S; Snyder SH
Neuropharmacology; 2011 Jun; 60(7-8):1187-92. PubMed ID: 21044641
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
[TBL] [Abstract][Full Text] [Related]
4. The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes.
Harrison LM; Lahoste GJ
Exp Cell Res; 2013 Sep; 319(15):2310-5. PubMed ID: 23583659
[TBL] [Abstract][Full Text] [Related]
5. Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.
Lee JH; Tecedor L; Chen YH; Monteys AM; Sowada MJ; Thompson LM; Davidson BL
Neuron; 2015 Jan; 85(2):303-15. PubMed ID: 25556834
[TBL] [Abstract][Full Text] [Related]
6. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.
Mealer RG; Murray AJ; Shahani N; Subramaniam S; Snyder SH
J Biol Chem; 2014 Feb; 289(6):3547-54. PubMed ID: 24324270
[TBL] [Abstract][Full Text] [Related]
7. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.
Subramaniam S; Sixt KM; Barrow R; Snyder SH
Science; 2009 Jun; 324(5932):1327-30. PubMed ID: 19498170
[TBL] [Abstract][Full Text] [Related]
8. Striatal Induction and Spread of the Huntington's Disease Protein: A Novel Rhes Route.
Subramaniam S
J Huntingtons Dis; 2022; 11(3):281-290. PubMed ID: 35871361
[TBL] [Abstract][Full Text] [Related]
9. Golgi protein ACBD3 mediates neurotoxicity associated with Huntington's disease.
Sbodio JI; Paul BD; Machamer CE; Snyder SH
Cell Rep; 2013 Sep; 4(5):890-7. PubMed ID: 24012756
[TBL] [Abstract][Full Text] [Related]
10. Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain.
Ramírez-Jarquín UN; Sharma M; Shahani N; Li Y; Boregowda S; Subramaniam S
Sci Adv; 2022 Mar; 8(12):eabm3877. PubMed ID: 35319973
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease.
Baiamonte BA; Lee FA; Brewer ST; Spano D; LaHoste GJ
PLoS One; 2013; 8(1):e53606. PubMed ID: 23349722
[TBL] [Abstract][Full Text] [Related]
12. Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model.
Pan Y; Tang B; Li XJ; Li S; Liu Q
Front Aging Neurosci; 2023; 15():1237018. PubMed ID: 37637962
[TBL] [Abstract][Full Text] [Related]
13. Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.
Desplats PA; Kass KE; Gilmartin T; Stanwood GD; Woodward EL; Head SR; Sutcliffe JG; Thomas EA
J Neurochem; 2006 Feb; 96(3):743-57. PubMed ID: 16405510
[TBL] [Abstract][Full Text] [Related]
14. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington's disease.
Pryor WM; Biagioli M; Shahani N; Swarnkar S; Huang WC; Page DT; MacDonald ME; Subramaniam S
Sci Signal; 2014 Oct; 7(349):ra103. PubMed ID: 25351248
[TBL] [Abstract][Full Text] [Related]
15. Global Rhes knockout in the Q175 Huntington's disease mouse model.
Heikkinen T; Bragge T; Kuosmanen J; Parkkari T; Gustafsson S; Kwan M; Beltran J; Ghavami A; Subramaniam S; Shahani N; Ramírez-Jarquín UN; Park L; Muñoz-Sanjuán I; Marchionini DM
PLoS One; 2021; 16(10):e0258486. PubMed ID: 34648564
[TBL] [Abstract][Full Text] [Related]
16. Rhes suppression enhances disease phenotypes in Huntington's disease mice.
Lee JH; Sowada MJ; Boudreau RL; Aerts AM; Thedens DR; Nopoulos P; Davidson BL
J Huntingtons Dis; 2014; 3(1):65-71. PubMed ID: 25062765
[TBL] [Abstract][Full Text] [Related]
17. Rhes: A striatal-specific Ras homolog related to Dexras1.
Falk JD; Vargiu P; Foye PE; Usui H; Perez J; Danielson PE; Lerner DL; Bernal J; Sutcliffe JG
J Neurosci Res; 1999 Sep; 57(6):782-8. PubMed ID: 10467249
[TBL] [Abstract][Full Text] [Related]
18. Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease.
Mealer RG; Subramaniam S; Snyder SH
J Neurosci; 2013 Feb; 33(9):4206-10. PubMed ID: 23447628
[TBL] [Abstract][Full Text] [Related]
19. Striatal expression of a calmodulin fragment improved motor function, weight loss, and neuropathology in the R6/2 mouse model of Huntington's disease.
Dai Y; Dudek NL; Li Q; Fowler SC; Muma NA
J Neurosci; 2009 Sep; 29(37):11550-9. PubMed ID: 19759302
[TBL] [Abstract][Full Text] [Related]
20. Loss of Hap1 selectively promotes striatal degeneration in Huntington disease mice.
Liu Q; Cheng S; Yang H; Zhu L; Pan Y; Jing L; Tang B; Li S; Li XJ
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20265-20273. PubMed ID: 32747555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
